Physician profile
Alyssa Schloop
NPI 1881115053
$1,684.07
in general payments reported to CMS, 2019-2025
21 companies · $326 in 2025
The $326 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $121 · 2022: $561 · 2023: $370 · 2024: $307 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,001.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $303.78 | 2022-2025 | Acessa Provu System, Myosure Tissue Removal Device, Fluent Fluid Management System |
| Sumitomo Pharma America, INC. | $191.35 | 2023-2025 | Myfembree |
| Aspira Women'S Health INC | $188.80 | 2022 | |
| Organon LLC | $163.74 | 2022-2025 | Nexplanon, Nuvaring |
| Abbvie INC. | $149.11 | 2021-2024 | Orilissa, Lo Loestrin Fe |
| Myovant Sciences INC. | $93.04 | 2021-2022 | |
| Exeltis, USA INC. | $85.33 | 2022-2024 | Slynd |
| Astellas Pharma US INC | $83.19 | 2023-2024 | Veozah |
| Sage Therapeutics, LLC | $77.73 | 2022-2024 | |
| Mayne Pharma Commercial LLC | $59.16 | 2021-2025 | |
| Daiichi Sankyo INC. | $44.81 | 2022-2024 | Vanflyta |
| Coopersurgical, INC. | $35.64 | 2024-2025 | Paragard T 380a |
| Agile Therapeutics, INC. | $32.71 | 2021-2023 | Twirla |
| Evofem Biosciences, INC. | $32.48 | 2021-2022 | |
| Myriad Women'S Health, INC. | $27.51 | 2023 | Myrisk |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $25.03 | 2024 | |
| Pfizer INC. | $20.18 | 2023 | |
| Molnlycke Health Care US, LLC | $19.19 | 2023 | Avance, Mepilex Border Post-Op |
| Gynesonics, INC. | $18.96 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Ethicon US, LLC | $18.31 | 2024 | Vistaseal, Enseal |
| Shield Therapeutics INC | $14.02 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyssa Schloop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.